Klaudia Konikowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Klaudia Konikowska has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Matera-Witkiewicz
Screening of Biological Activity Assays and Collection of Biological Material Laboratory, Wroclaw Medical University Biobank, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland
3 shared publications - Andrzej Szuba
Department of Angiology and Internal Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
3 shared publications - Katarzyna Kiliś-Pstrusińska
Clinical Department of Paediatric Nephrology, Faculty of Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland
3 shared publications - Krzysztof Kujawa
Statistical Analysis Center, Wroclaw Medical University, 50-368 Wroclaw, Poland
3 shared publications - Adrian Doroszko
Faculty of Medicine, Wroclaw University of Science and Technology, 50-981 Wroclaw, Poland
2 shared publications - Barbara Adamik
Clinical Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
2 shared publications
Latest Publications
- Open Access
Assessment of Health Status, Emotional Well-Being, and the Prevalence of Overweight and Obesity in Children and Adolescents in the PICTURE Study (Wroclaw, Poland)
Objective: The aim of the study was to analyze the assessment of the health and emotional well-being of children and adolescents from Wroclaw, including the frequency of diseases, health symptoms, overweight, and obesity. Methods: The study was conducted as a cross-sectional study between 2019–2023, ultimately involving 1232 children aged 7–17 years. The data were collected in the form of interviews with caregivers. The study used a health questionnaire, anthropometric measurements and laboratory tests. Overweight and obesity were determined based on Polish body mass index (BMI) percentile tables in accordance with pediatric society guidelines. For the purposes of analysis, participants were divided into three age groups: 6–9, 10–12, and 13–17 years old. Results: The most common diagnosis was allergies, affecting about 36% of those surveyed. In total, 32.8% of children reported difficulties with concentration, memory, and learning. Emotionally, over one-third of children experienced anxiety or fear and outbursts of anger, 26% experienced inadequate sadness, and about 22% complained of chronic fatigue and excessive agitation. About 15% of participants reported symptoms of depression. Overweight and obesity were present in about 18% of children, with the frequency increasing with age. Moreover, it was shown that gender and age were the most important factors differentiating the risk of emotional symptoms, while body weight had no significant effect on any of the analyzed symptoms. Conclusions: The study revealed a significant prevalence of emotional disorders among children and adolescents, an increasing prevalence of allergies with age, and the growing problem of overweight and obesity. The results indicate the need for the implementation of systematic preventive measures and the early diagnosis of chronic diseases. An effective response to these challenges requires the development of an interdisciplinary healthcare model that integrates pediatric, psychologist, dietary, and social support.
Open AccessAssessment of Health Status, Emotional Well-Being, and the Prevalence of Overweight and Obesity in Children and Adolescents in the PICTURE Study (Wroclaw, Poland)
Objective: The aim of the study was to analyze the assessment of the health and emotional well-being of children and adolescents from Wroclaw, including the frequency of diseases, health symptoms, overweight, and obesity. Methods: The study was conducted as a cross-sectional study between 2019–2023, ultimately involving 1232 children aged 7–17 years. The data were collected in the form of interviews with caregivers. The study used a health questionnaire, anthropometric measurements and laboratory tests. Overweight and obesity were determined based on Polish body mass index (BMI) percentile tables in accordance with pediatric society guidelines. For the purposes of analysis, participants were divided into three age groups: 6–9, 10–12, and 13–17 years old. Results: The most common diagnosis was allergies, affecting about 36% of those surveyed. In total, 32.8% of children reported difficulties with concentration, memory, and learning. Emotionally, over one-third of children experienced anxiety or fear and outbursts of anger, 26% experienced inadequate sadness, and about 22% complained of chronic fatigue and excessive agitation. About 15% of participants reported symptoms of depression. Overweight and obesity were present in about 18% of children, with the frequency increasing with age. Moreover, it was shown that gender and age were the most important factors differentiating the risk of emotional symptoms, while body weight had no significant effect on any of the analyzed symptoms. Conclusions: The study revealed a significant prevalence of emotional disorders among children and adolescents, an increasing prevalence of allergies with age, and the growing problem of overweight and obesity. The results indicate the need for the implementation of systematic preventive measures and the early diagnosis of chronic diseases. An effective response to these challenges requires the development of an interdisciplinary healthcare model that integrates pediatric, psychologist, dietary, and social support.
- Open Access
- 28 January 2025
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 19 (1) , 48-53
Insights into diet, psychological distress, and personality traits among patients with lower-extremity lymphedema and overweight/obesity in comparison to patients with lifestyle-induced overweight/obesity and patients with normal body weight
- 28 January 2025
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 19 (1) , 48-53
Open AccessInsights into diet, psychological distress, and personality traits among patients with lower-extremity lymphedema and overweight/obesity in comparison to patients with lifestyle-induced overweight/obesity and patients with normal body weight
- Open Access
- 1 January 2024
- Published by Wroclaw University of Economics and Business in Engineering Sciences And Technologies
- Vol. 2024 (40) , 86-97
Mobile Apps for Allergies: A Systematic Review and Quality Assessment Using the Mobile Application Rating Scale (MARS)
Aim: With the growing reliance on mobile apps by individuals with allergies and food intolerances, this study aimed to evaluate their quality and usability. Using the Mobile Application Rating Scale (MARS), we assessed allergy-related apps available on Google Play and the AppStore. Methodology: Using the PRISMA elimination method (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), three apps were selected from the available options: Soosee – Allergy & Vegan Scan, The Gluten Free Scanner, and Eat Smart Kiwi: Food Diary. The respondents used these apps for a period of two weeks. Next, the researchers completed the MARS questionnaire, comprising five sections. The apps were evaluated in the categories of engagement, functionality, aesthetics, information content, and subjective quality assessment. Results: The study revealed that one of the apps, namely Soosee – Allergy & Vegan Scan, received the highest ratings among the apps evaluated, surpassing Eat Smart Kiwi: Food Diary and The Gluten Free Scanner, which received the lowest rating. Analysis of user preferences indicated that the aesthetics of the interface play a crucial role in the perception of mHealth mobile apps, particularly those related to food allergies. An attractive graphical interface significantly impacts user satisfaction and engagement. Notably, the ratings given by the study participants did not align with those seen on Google Play and the AppStore, suggesting potential differences in user expectations and needs depending on usage context and the more detailed assessment conducted in this study. Implications and recommendations: With numerous mobile apps available, quality assessment is crucial as users often lack the knowledge to evaluate them effectively. While mHealth apps have the potential to improve daily life for individuals with allergies, they must offer an intuitive design, verified information, and user-friendly interfaces to meet expectations. Originality/value: This study provides a comprehensive evaluation of allergy-related mobile apps using a standardized assessment tool (MARS), offering a more structured analysis than general user ratings. By highlighting discrepancies between expert-based evaluations and user reviews, the research underscores the need for more transparent quality indicators in mHealth applications.
- 1 January 2024
- Published by Wroclaw University of Economics and Business in Engineering Sciences And Technologies
- Vol. 2024 (40) , 86-97
Open AccessMobile Apps for Allergies: A Systematic Review and Quality Assessment Using the Mobile Application Rating Scale (MARS)
Aim: With the growing reliance on mobile apps by individuals with allergies and food intolerances, this study aimed to evaluate their quality and usability. Using the Mobile Application Rating Scale (MARS), we assessed allergy-related apps available on Google Play and the AppStore. Methodology: Using the PRISMA elimination method (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), three apps were selected from the available options: Soosee – Allergy & Vegan Scan, The Gluten Free Scanner, and Eat Smart Kiwi: Food Diary. The respondents used these apps for a period of two weeks. Next, the researchers completed the MARS questionnaire, comprising five sections. The apps were evaluated in the categories of engagement, functionality, aesthetics, information content, and subjective quality assessment. Results: The study revealed that one of the apps, namely Soosee – Allergy & Vegan Scan, received the highest ratings among the apps evaluated, surpassing Eat Smart Kiwi: Food Diary and The Gluten Free Scanner, which received the lowest rating. Analysis of user preferences indicated that the aesthetics of the interface play a crucial role in the perception of mHealth mobile apps, particularly those related to food allergies. An attractive graphical interface significantly impacts user satisfaction and engagement. Notably, the ratings given by the study participants did not align with those seen on Google Play and the AppStore, suggesting potential differences in user expectations and needs depending on usage context and the more detailed assessment conducted in this study. Implications and recommendations: With numerous mobile apps available, quality assessment is crucial as users often lack the knowledge to evaluate them effectively. While mHealth apps have the potential to improve daily life for individuals with allergies, they must offer an intuitive design, verified information, and user-friendly interfaces to meet expectations. Originality/value: This study provides a comprehensive evaluation of allergy-related mobile apps using a standardized assessment tool (MARS), offering a more structured analysis than general user ratings. By highlighting discrepancies between expert-based evaluations and user reviews, the research underscores the need for more transparent quality indicators in mHealth applications.
- Open Access
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1231813
Association of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19
Background: Vitamin D deficiency is a substantial public health problem. The present study evaluated the association between vitamin D concentration and hospitalization and mortality risk in patients with coronavirus disease 19 (COVID-19).Methods: This study used the COronavirus in LOwer Silesia (COLOS) dataset collected between February 2020 and June 2021. The medical records of 474 patients with confirmed severe acute respiratory syndrome 2 (SARS-CoV-2) infection, and whose vitamin D concentration was measured, were analyzed.Results: We determined a significant difference in vitamin D concentration between discharged patients and those who died during hospitalization (p = 0.0096). We also found an effect of vitamin D concentration on the risk of death in patients hospitalized due to COVID-19. As vitamin D concentration increased, the odds ratio (OR) for death slightly decreased (OR = 0.978; 95% confidence interval [CI] = 0.540-0.669). The vitamin D concentration cutoff point was 15.40 ng/ml. In addition, patients with COVID-19 and serum 25-hydroxyvitamin D (25(OH)D) concentrations < 30 ng/ml had a lower survival rate than those with serum 25(OH)D ≥ 30 ng/ml (log-rank test p = 0.0018). Moreover, a Cox regression model showed that patients with an estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2 and higher vitamin D concentrations had a 2.8% reduced risk of mortality (hazard ratio HR = 0.972; CI = 0.95-0,99; p = 0.0097).Conclusions: The results indicate an association between 25(OH)D levels in patients with COVID-19 and the final course of hospitalization and risk of death.
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1231813
Open AccessAssociation of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19
Background: Vitamin D deficiency is a substantial public health problem. The present study evaluated the association between vitamin D concentration and hospitalization and mortality risk in patients with coronavirus disease 19 (COVID-19).Methods: This study used the COronavirus in LOwer Silesia (COLOS) dataset collected between February 2020 and June 2021. The medical records of 474 patients with confirmed severe acute respiratory syndrome 2 (SARS-CoV-2) infection, and whose vitamin D concentration was measured, were analyzed.Results: We determined a significant difference in vitamin D concentration between discharged patients and those who died during hospitalization (p = 0.0096). We also found an effect of vitamin D concentration on the risk of death in patients hospitalized due to COVID-19. As vitamin D concentration increased, the odds ratio (OR) for death slightly decreased (OR = 0.978; 95% confidence interval [CI] = 0.540-0.669). The vitamin D concentration cutoff point was 15.40 ng/ml. In addition, patients with COVID-19 and serum 25-hydroxyvitamin D (25(OH)D) concentrations < 30 ng/ml had a lower survival rate than those with serum 25(OH)D ≥ 30 ng/ml (log-rank test p = 0.0018). Moreover, a Cox regression model showed that patients with an estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2 and higher vitamin D concentrations had a 2.8% reduced risk of mortality (hazard ratio HR = 0.972; CI = 0.95-0,99; p = 0.0097).Conclusions: The results indicate an association between 25(OH)D levels in patients with COVID-19 and the final course of hospitalization and risk of death.
- Open Access
- 23 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (2) , 317
A High-Quality Diet, as Measured by the DASH Score, Is Associated with a Lower Risk of Metabolic Syndrome and Visceral Obesity
The current study was designed to examine the relationship between diet quality, as measured by the Dietary Approaches to Stop Hypertension (DASH) score, and the prevalence of metabolic syndrome (MetS) and its components. The study was cross-sectional in design and enrolled 535 people, including 215 with MetS and 320 without MetS. Using a validated food frequency questionnaire, the DASH diet quality score was counted. The mean age of the MetS group and control subjects was 58.48 ± 14.65 and 58.33 ± 9.26 years, respectively. The study showed that the MetS group had a significantly lower mean total DASH score than the control group (23.13 ± 5.44 vs. 24.62 ± 5.07, p = 0.0023). In addition, it was found that an increase in the total DASH score was associated with a lower risk of MetS (odds ratio [OR] = 0.95, 95% confidence interval [CI] = 0.91–0.99, p = 0.009). In the correlation analysis of the total population, a better-quality diet (higher DASH score) was positively correlated with high-density lipoprotein cholesterol (HDL-c), and negatively correlated with triglyceride (TG) concentration and waist circumference. It was also found that an increase in the total DASH score was associated with a lower risk of abdominal obesity (OR = 0.93, 95% CI = 0.88–0.99, p = 0.017). The results from the analyzed data highlight the potential benefits of following a healthy diet such as DASH.
- 23 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (2) , 317
Open AccessA High-Quality Diet, as Measured by the DASH Score, Is Associated with a Lower Risk of Metabolic Syndrome and Visceral Obesity
The current study was designed to examine the relationship between diet quality, as measured by the Dietary Approaches to Stop Hypertension (DASH) score, and the prevalence of metabolic syndrome (MetS) and its components. The study was cross-sectional in design and enrolled 535 people, including 215 with MetS and 320 without MetS. Using a validated food frequency questionnaire, the DASH diet quality score was counted. The mean age of the MetS group and control subjects was 58.48 ± 14.65 and 58.33 ± 9.26 years, respectively. The study showed that the MetS group had a significantly lower mean total DASH score than the control group (23.13 ± 5.44 vs. 24.62 ± 5.07, p = 0.0023). In addition, it was found that an increase in the total DASH score was associated with a lower risk of MetS (odds ratio [OR] = 0.95, 95% confidence interval [CI] = 0.91–0.99, p = 0.009). In the correlation analysis of the total population, a better-quality diet (higher DASH score) was positively correlated with high-density lipoprotein cholesterol (HDL-c), and negatively correlated with triglyceride (TG) concentration and waist circumference. It was also found that an increase in the total DASH score was associated with a lower risk of abdominal obesity (OR = 0.93, 95% CI = 0.88–0.99, p = 0.017). The results from the analyzed data highlight the potential benefits of following a healthy diet such as DASH.
- Open Access
- 5 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2487
Metabolic Syndrome Is Associated with Low Diet Quality Assessed by the Healthy Eating Index-2015 (HEI-2015) and Low Concentrations of High-Density Lipoprotein Cholesterol
Presenting diet quality of patients with metabolic syndrome (MetS), using a holistic approach is more useful than investigating dietary individual components, but there is still a small amount of research in this area. The aim of this study assessed the diet quality, as measured by the HEI-2015, of MetS patients compared to healthy individuals. The study and control group consisted of 215 patients with MetS and 320 people without MetS, respectively. A nutritional analysis using a semi-quantitative food frequency questionnaire was used to evaluate the nutritional habits in the study and control group. Total HEI-2015 scores were significantly lower in MetS subjects than in those in the control group (65.04 ± 9.71 vs. 66.75 ± 8.88) and the quality of women’s diets was better than the quality of men’s diet (66.83 ± 8.99 vs. 64.75 ± 9.57). We also observed that low HDL-c concentration increased the risk of MetS in the general population the most. Across the population, there was a weak positive correlation between HDL-c concentrations and total HEI-2015 scores and a weak negative correlation between mean waist circumference values and total HEI-2015 scores. HDL-c concentrations may be a key factor in the prevention of MetS and appropriate therapeutic management to increase HDL-c levels may be of key importance in patients diagnosed with MetS.
- 5 October 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2487
Open AccessMetabolic Syndrome Is Associated with Low Diet Quality Assessed by the Healthy Eating Index-2015 (HEI-2015) and Low Concentrations of High-Density Lipoprotein Cholesterol
Presenting diet quality of patients with metabolic syndrome (MetS), using a holistic approach is more useful than investigating dietary individual components, but there is still a small amount of research in this area. The aim of this study assessed the diet quality, as measured by the HEI-2015, of MetS patients compared to healthy individuals. The study and control group consisted of 215 patients with MetS and 320 people without MetS, respectively. A nutritional analysis using a semi-quantitative food frequency questionnaire was used to evaluate the nutritional habits in the study and control group. Total HEI-2015 scores were significantly lower in MetS subjects than in those in the control group (65.04 ± 9.71 vs. 66.75 ± 8.88) and the quality of women’s diets was better than the quality of men’s diet (66.83 ± 8.99 vs. 64.75 ± 9.57). We also observed that low HDL-c concentration increased the risk of MetS in the general population the most. Across the population, there was a weak positive correlation between HDL-c concentrations and total HEI-2015 scores and a weak negative correlation between mean waist circumference values and total HEI-2015 scores. HDL-c concentrations may be a key factor in the prevention of MetS and appropriate therapeutic management to increase HDL-c levels may be of key importance in patients diagnosed with MetS.
- Open Access
- 18 February 2022
- Published by MDPI AG in Education Sciences
- Vol. 12 (2) , 136
From PKU Online Lessons for Dietetics Students to the PKU Sandwiches Album
The purpose of the manuscript is to present to academic teachers, doctors and nutritionists how practical online classes with dietetics students can be used to develop ready-made tools at work and for the education of phenylketonuria (PKU) patients and their caregivers/parents. During online classes in 2020, as part of the subject—diet therapy of metabolic blocks, 53 students prepared PKU sandwiches at home. Each PKU sandwich has a calculated nutritional value, and phenylalanine exchanger content, but does not include low-protein bread. The selection of a particular type of PKU bread depends solely on the PKU patient, hence it was deliberately not included in the calculations. The sandwiches, made by students and assessed by academic teachers, will be published with the following title “The PKU Sandwiches Album”. The Album with more than 400 colorful pictures of PKU sandwiches, will be expected to inspire patients and help them add appeal to their diet, enriching it with new tastes, at the same time facilitating the memorizing process of ingredients, thanks to visualization and presented calculations, and motivating them to comply with strict dietary recommendation. The same nutritional calculations and ideas for sandwiches, with the use of different bread, e.g., gluten-free, may be useful in other diseases, such as celiac disease.
- 18 February 2022
- Published by MDPI AG in Education Sciences
- Vol. 12 (2) , 136
Open AccessFrom PKU Online Lessons for Dietetics Students to the PKU Sandwiches Album
The purpose of the manuscript is to present to academic teachers, doctors and nutritionists how practical online classes with dietetics students can be used to develop ready-made tools at work and for the education of phenylketonuria (PKU) patients and their caregivers/parents. During online classes in 2020, as part of the subject—diet therapy of metabolic blocks, 53 students prepared PKU sandwiches at home. Each PKU sandwich has a calculated nutritional value, and phenylalanine exchanger content, but does not include low-protein bread. The selection of a particular type of PKU bread depends solely on the PKU patient, hence it was deliberately not included in the calculations. The sandwiches, made by students and assessed by academic teachers, will be published with the following title “The PKU Sandwiches Album”. The Album with more than 400 colorful pictures of PKU sandwiches, will be expected to inspire patients and help them add appeal to their diet, enriching it with new tastes, at the same time facilitating the memorizing process of ingredients, thanks to visualization and presented calculations, and motivating them to comply with strict dietary recommendation. The same nutritional calculations and ideas for sandwiches, with the use of different bread, e.g., gluten-free, may be useful in other diseases, such as celiac disease.
- Open Access
- 7 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 873
Usefulness of the C2HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual C2HEST components reflect the comorbidities, we assumed that the score could predict COVID-19 outcomes. Material and Methods: A total of 2184 medical records of patients hospitalized for COVID-19 at the medical university center were analyzed, including 473 diabetic patients and 1666 patients without any glucose or metabolic abnormalities. The variables of patients’ baseline characteristics were retrieved to calculate the C2HEST score and subsequently the diabetic and non-diabetic subjects were assigned to the following categories: low-, medium- or high-risk. The measured outcomes included: in-hospital mortality; 3-month and 6-month all-cause mortality; non-fatal end of hospitalization (discharged home/sudden-deterioration/rehabilitation) and adverse in-hospital clinical events. Results: A total of 194 deaths (41%) were reported in the diabetic cohort, including 115 in-hospital deaths (24.3%). The 3-month and 6-month in-hospital mortality was highest in the high-risk C2HEST stratum. The C2HEST score revealed to be more sensitive in non-diabetic-group. The estimated six-month survival probability for high-risk subjects reached 0.4 in both cohorts whereas for the low-risk group, the six-month survival probability was 0.7 in the diabetic vs. 0.85 in the non-diabetic group—levels which were maintained during whole observation period. In both cohorts, receiver operating characteristics revealed that C2HEST predicts the following: cardiogenic shock; acute heart failure; myocardial injury; and in-hospital acute kidney injury. Conclusions: We demonstrated the usefulness and performance of the C2HEST score in predicting the adverse COVID-19 outcomes in hospitalized diabetic subjects.
- 7 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 873
Open AccessUsefulness of the C2HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual C2HEST components reflect the comorbidities, we assumed that the score could predict COVID-19 outcomes. Material and Methods: A total of 2184 medical records of patients hospitalized for COVID-19 at the medical university center were analyzed, including 473 diabetic patients and 1666 patients without any glucose or metabolic abnormalities. The variables of patients’ baseline characteristics were retrieved to calculate the C2HEST score and subsequently the diabetic and non-diabetic subjects were assigned to the following categories: low-, medium- or high-risk. The measured outcomes included: in-hospital mortality; 3-month and 6-month all-cause mortality; non-fatal end of hospitalization (discharged home/sudden-deterioration/rehabilitation) and adverse in-hospital clinical events. Results: A total of 194 deaths (41%) were reported in the diabetic cohort, including 115 in-hospital deaths (24.3%). The 3-month and 6-month in-hospital mortality was highest in the high-risk C2HEST stratum. The C2HEST score revealed to be more sensitive in non-diabetic-group. The estimated six-month survival probability for high-risk subjects reached 0.4 in both cohorts whereas for the low-risk group, the six-month survival probability was 0.7 in the diabetic vs. 0.85 in the non-diabetic group—levels which were maintained during whole observation period. In both cohorts, receiver operating characteristics revealed that C2HEST predicts the following: cardiogenic shock; acute heart failure; myocardial injury; and in-hospital acute kidney injury. Conclusions: We demonstrated the usefulness and performance of the C2HEST score in predicting the adverse COVID-19 outcomes in hospitalized diabetic subjects.
- Open Access
- 25 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5522
Kidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes
The disease caused by coronavirus SARS-CoV-2 (COVID-19) can affect almost all organs of the human body, including kidneys. We conducted a one-center study to comprehensively analyze the effects of kidney involvement on the course and outcomes in patients hospitalized with COVID-19, depending on the estimated glomerular filtration rate (eGFR) at admission. Out of the 1958 patients, 1342 (68.54%) had eGFR ≥ 60 mL/min/1.73 m2 (group A) and 616 (31.46%) had eGFR < 60 mL/min/1.73 m2 (group B). Group B was additionally divided into subgroups B1, B2, and B3 based on eGFR. We found that mortality rates during hospitalization, as well as after 90 and 180 days, were much higher in group B than group A. The highest mortality was observed in the B2 subgroup with eGFR of 15–29. The mortality of B patients was associated with comorbidities, respiratory dysfunction, immunological impairment, and more frequent development of AKI. AKI had a negative impact on patients’ survival, regardless of the initial renal function. At discharge, 7.4% of patients had serum creatinine levels 30% higher, or more, as compared to admission. The disease course and outcomes in COVID-19 patients are associated with baseline eGFR; however, AKI during hospitalization is a more significant predictor of poor prognosis regardless of the initial renal function.
- 25 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5522
Open AccessKidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes
The disease caused by coronavirus SARS-CoV-2 (COVID-19) can affect almost all organs of the human body, including kidneys. We conducted a one-center study to comprehensively analyze the effects of kidney involvement on the course and outcomes in patients hospitalized with COVID-19, depending on the estimated glomerular filtration rate (eGFR) at admission. Out of the 1958 patients, 1342 (68.54%) had eGFR ≥ 60 mL/min/1.73 m2 (group A) and 616 (31.46%) had eGFR < 60 mL/min/1.73 m2 (group B). Group B was additionally divided into subgroups B1, B2, and B3 based on eGFR. We found that mortality rates during hospitalization, as well as after 90 and 180 days, were much higher in group B than group A. The highest mortality was observed in the B2 subgroup with eGFR of 15–29. The mortality of B patients was associated with comorbidities, respiratory dysfunction, immunological impairment, and more frequent development of AKI. AKI had a negative impact on patients’ survival, regardless of the initial renal function. At discharge, 7.4% of patients had serum creatinine levels 30% higher, or more, as compared to admission. The disease course and outcomes in COVID-19 patients are associated with baseline eGFR; however, AKI during hospitalization is a more significant predictor of poor prognosis regardless of the initial renal function.
- Open Access
- 1 January 2015
- Published by Wroclaw Medical University in Nursing and Public Health
- Vol. 5 (4) , 417-425
The Role of Diet in the Development of Prostate Cancer
- 1 January 2015
- Published by Wroclaw Medical University in Nursing and Public Health
- Vol. 5 (4) , 417-425
Open AccessThe Role of Diet in the Development of Prostate Cancer